-
Mashup Score: 3N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes - 4 year(s) ago
Abstract Objectives The purpose of this study was to examine the treatment effect of vericiguat in relation to N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels at randomization. Backgro…
Source: JACC: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Reduction in CMR Derived Extracellular Volume with Patisiran Indicates Cardiac Amyloid Regression - 4 year(s) ago
Abstract Objectives The purpose of this study was to determine the effect of patisiran on the cardiac amyloid load as measured by cardiac magnetic resonance and extracellular volume (ECV) mapping i…
Source: JACC: Cardiovascular ImagingCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction - 4 year(s) ago
Objectives This study examined the effects of sacubitril/valsartan on N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels and determined patient characteristics associated with favorable NT-proBNP reduction response. Background NT-proBNP levels reflect cardiac wall stress and predict event risk in patients with acute decompensated heart failure (ADHF). Methods Post-hoc analysis of the…
Source: JACC: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
What is vericiguat's relationship to #NTproBNP and outcomes? Check out this study by Dr. @JustinEzekowitz in #JACCHF. https://t.co/8cAutsGZao @coconnormd @texhern https://t.co/7LT2m5rGNX